MADRIGAL PHARMACEUTICALS, INC.

Lobbying for MADRIGAL PHARMACEUTICALS, INC. · Biopharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Pennsylvania · House · Senate · $380,000.00 expenses · posted Apr 24, 2026

Lobbying activity 2

Medicare/Medicaid

Issues related to CMMI drug pricing; 340B drug pricing

Health Issues

Most Favored Nation drug pricing; Issues related to CMMI drug pricing

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.